CVE Feed

    Dashboard / CVE / CVE-2017-17678

    CVE-2017-17678

    BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

    Published:May 19, 2021
    Last Modified:Nov 21, 2024
    EPS:May 19, 2021
    EPSS Score:0.00465
    CVSS Score:6.1

    Affected Products

    Vendor
    Bmc
    Product
    Remedy Mid-tier

    Exploits

    No exploit reference

    Related CVEs

    CVE-2024-34398 (CVSS 4.2) — An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by aut…
    CVE-2024-34399 (CVSS 9.8) — **UNSUPPORTED WHEN ASSIGNED** An issue was discovered in BMC Remedy Mid Tier 7.6.04. An unauthenticated remote…
    CVE-2017-17677 (CVSS 8.8) — BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to crea…
    CVE-2017-17675 (CVSS 5.3) — BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Remote logging can be accessed by unauthenticated use…
    CVE-2017-17674 (CVSS 9.8) — BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on …
    CVE-2018-18862 (CVSS 8.8) — BMC Remedy Mid-Tier 7.1.00 and 9.1.02.003 for BMC Remedy AR System has Incorrect Access Control in ITAM forms,…

    Common Vulnerability Scoring System

    Attack Vector
    Network
    Adjacent
    Local
    Physical
    Privileges Required
    None
    Low
    High
    User Interaction
    None
    Required
    Scope
    Unchanged
    Changed
    Confidentiality
    None
    Low
    High
    Integrity
    None
    Low
    High
    Availability
    None
    Low
    High